Intrinsic Value of S&P & Nasdaq Contact Us

Kymera Therapeutics, Inc. KYMR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$117.31
+30.5%

Kymera Therapeutics, Inc. (KYMR) has 12 identified peers for comparison in the Healthcare sector. Peers include AGIO, CCCC, CGEM, ELYM, EWTX, FHTX and others.

KYMR has a market capitalization of $7.34B, compared to an average peer market cap of $3.43B. KYMR is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message